Keros Therapeutics Stock Price on December 2, 2024
| KROS Stock | USD 66.31 0.83 1.24% |
Below is the normalized historical share price chart for Keros Therapeutics extending back to April 08, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Keros Therapeutics stands at 66.31, as last reported on the 11th of December 2024, with the highest price reaching 68.44 and the lowest price hitting 65.86 during the day.
If you're considering investing in Keros Stock, it is important to understand the factors that can impact its price. Keros Therapeutics appears to be very steady, given 3 months investment horizon. Keros Therapeutics has Sharpe Ratio of 0.0966, which conveys that the firm had a 0.0966% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Keros Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Keros Therapeutics' Risk Adjusted Performance of 0.0917, downside deviation of 2.66, and Mean Deviation of 2.36 to check out if our risk estimates are consistent with your expectations.
At this time, Keros Therapeutics' Stock Based Compensation is comparatively stable compared to the past year. Stock Based Compensation To Revenue is likely to gain to 180.01 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 207.7 M in 2024. . At this time, Keros Therapeutics' Price To Sales Ratio is comparatively stable compared to the past year. Price Sales Ratio is likely to gain to 7,327 in 2024, whereas Price Earnings Ratio is likely to drop (8.04) in 2024. Keros Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of April 2020 | 200 Day MA 55.5916 | 50 Day MA 60.2784 | Beta 1.236 |
Keros |
Sharpe Ratio = 0.0966
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KROS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.17 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.31 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Keros Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Keros Therapeutics by adding it to a well-diversified portfolio.
Price Book 5.3216 | Enterprise Value Ebitda (13.05) | Price Sales 4.2 K | Shares Float 35.4 M | Wall Street Target Price 91.4615 |
Related Headline
Janux Therapeutics Headline on 2nd of December 2024
Janux shares surge on promising JANX007 prostate cancer tria... by investing.com
Janux shares surge on promising JANX007 prostate cancer trial
Keros Therapeutics Valuation on December 2, 2024
It is possible to determine the worth of Keros Therapeutics on a given historical date. On December 2, 2024 Keros was worth 57.5 at the beginning of the trading date compared to the closed value of 56.73. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Keros Therapeutics stock. Still, in general, we apply an absolute valuation method to find Keros Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Keros Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Keros Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 58.60 | 58.97 | 57.25 | 57.74 | 125,835 | |
12/02/2024 | 57.50 | 58.05 | 56.10 | 56.73 | 424,864 |
| 56.64 | 62.42 | 56.64 | 62.28 | 595,015 |
| Backtest Keros Therapeutics | | | Keros Therapeutics History | | | Keros Therapeutics Valuation | Previous | Next |
Keros Therapeutics Trading Date Momentum on December 2, 2024
| On December 03 2024 Keros Therapeutics was traded for 62.28 at the closing time. The top price for the day was 62.42 and the lowest listed price was 56.64 . The trading volume for the day was 595 K. The trading history from December 3, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 9.78% . The trading delta at closing time against the current closing price is 18.60% . |
Keros Therapeutics Fundamentals Correlations and Trends
By evaluating Keros Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Keros Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Keros financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Keros Therapeutics Stock history
Keros Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Keros is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Keros Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Keros Therapeutics stock prices may prove useful in developing a viable investing in Keros Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.4 M | 20.4 M | |
| Net Loss | -94.2 M | -89.5 M |
Keros Therapeutics Quarterly Net Working Capital |
|
Keros Therapeutics Stock Technical Analysis
Keros Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Keros Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Keros Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Keros Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Keros Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Keros Therapeutics shares will generate the highest return on investment. By undertsting and applying Keros Therapeutics stock market strength indicators, traders can identify Keros Therapeutics entry and exit signals to maximize returns
Keros Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Keros Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Keros Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Keros to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0917 | |||
| Jensen Alpha | 0.1423 | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.0893 | |||
| Treynor Ratio | 0.1921 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Keros Stock Analysis
When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.